Collegium Pharmaceutical (COLL) reported $177.76 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 22.7$1.49 for the same period compares to $1.45 a year ago.The reported revenue compares to the Zacks Consensus Estimate of$172.45 million, representing a surprise of +3.08%. The company delivered an EPS surprise of +4.20%, with the consensus EPS estimate being $1.43.While investors scrutinize revenue and earnings changes year-over-year and how they compa ...